NCT01052506 BIIB033 Single Ascending Dose Study in Healthy Volunteer Subjects Status COMPLETED Phase PHASE1
NCT01051349 Safety and Efficacy Extension Study of Daclizumab High Yield Process (DAC HYP) (BIIB019) in Participants Who Have Completed Study 205MS202 (NCT00870740) to Treat Relapsing Remitting Multiple Sclerosis Status COMPLETED Phase PHASE2
NCT01017666 BIIB014 Effects on the Pharmacokinetics (PK) of Rosiglitazone, Warfarin, and Midazolam Status COMPLETED Phase PHASE1
NCT01017198 Effect of Food and Antacid on BIIB021 With Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT01004081 Hormone Receptor Positive Metastatic Breast Cancer (HR+ mBC) BIIB021 Plus Aromasin Schedule Finding Status COMPLETED Phase PHASE2
NCT00970580 A Study of BIIB022 in Combination With Paclitaxel and Carboplatin in Subjects With Non-Small Cell Lung Cancer Status COMPLETED Phase PHASE1
NCT00964288 Effect of GSK1014802 on Electrical Hyperalgesia and Threshold Tracking in Healthy Subjects Status TERMINATED Phase PHASE1
NCT00961766 Evaluate the Safety, Tolerability and Pharmacokinetics of BG00010 (Neublastin) Administered to Sciatica Participants Status COMPLETED Phase PHASE1
NCT00955396 Study to Investigate the Effect of GSK1014802 on Ambulatory Blood Pressure Status COMPLETED Phase PHASE1
NCT00937677 Effect of Tysabri in Patients With Relapsing-Remitting Multiple Sclerosis: A Follow-up Magnetization Transfer Imaging (MTI) Study Status COMPLETED Phase N/A
NCT00915577 Patient Satisfaction Study of Single-Use Autoinjector for the Delivery of Pre-Filled Avonex Syringe Status COMPLETED Phase PHASE3
NCT00913666 Pharmacodynamic Study to Better Understand the Therapeutic Response and Immunomodulatory Effects of Avonex in Multiple Sclerosis (MS) Patients and Healthy Volunteers Status COMPLETED Phase PHASE4
NCT00913250 A Bioequivalence Study of Serum Free Avonex and Serum Containing Avonex in Healthy Volunteers Status COMPLETED Phase PHASE1
NCT00908154 Safety, Tolerability and Pharmacokinetics of Repeat Doses of GSK1014802. Status COMPLETED Phase PHASE1
NCT00906399 Efficacy and Safety Study of Peginterferon Beta-1a in Participants With Relapsing Multiple Sclerosis Status COMPLETED Phase PHASE3
NCT00884481 Effects of Tysabri (BG00002) Over 12 Months on MS Related Fatigue in Participants With RRMS Status COMPLETED Phase N/A